1. Home
  2. ATI vs HALO Comparison

ATI vs HALO Comparison

Compare ATI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATI Inc.

ATI

ATI Inc.

HOLD

Current Price

$109.21

Market Cap

11.2B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$62.22

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATI
HALO
Founded
1960
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATI
HALO
Price
$109.21
$62.22
Analyst Decision
Strong Buy
Buy
Analyst Count
7
12
Target Price
$105.43
$73.33
AVG Volume (30 Days)
1.4M
2.5M
Earning Date
02-03-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
18.88
56.68
EPS
3.10
4.74
Revenue
$4,583,000,000.00
$1,242,852,000.00
Revenue This Year
$6.49
$34.83
Revenue Next Year
$8.40
$24.84
P/E Ratio
$35.13
$13.14
Revenue Growth
7.75
31.19
52 Week Low
$39.23
$46.26
52 Week High
$111.22
$79.50

Technical Indicators

Market Signals
Indicator
ATI
HALO
Relative Strength Index (RSI) 71.78 34.09
Support Level $98.10 $61.23
Resistance Level $111.22 $63.26
Average True Range (ATR) 3.23 2.42
MACD 0.72 -0.79
Stochastic Oscillator 87.53 7.60

Price Performance

Historical Comparison
ATI
HALO

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: